Elanco uncertainty has Greenfield on edge
Since October, when Eli Lilly and Co. announced it was reviewing whether to sell or spin off Elanco, Greenfield city leaders have been wondering what the future holds for the city’s economy.
Since October, when Eli Lilly and Co. announced it was reviewing whether to sell or spin off Elanco, Greenfield city leaders have been wondering what the future holds for the city’s economy.
The shakeup means that Rafael Sanchez, who has led the Indianapolis operations since June 2016, is out and will be replaced by a company official who will lead both Indiana and Ohio operations.
Many rural counties, where the outbreaks are occurring in tandem with the opioid crisis, have few if any doctors who specialize in liver care or infectious diseases. The new program conducts virtual clinics to share information on complex treatments.
The Indianapolis-based insurer, which already has reaped more than $1 billion from recent tax reform measures, plans to help employees sock it away.
Barely two weeks after being confirmed as U.S. Secretary for Health and Human Services, former Eli Lilly and Co. executive Alex Azar is returning to Indianapolis on Friday for an announcement with state officials.
The Carmel-based developer and operator sold the two properties to Invesque, a public company it created and shares an address with.
The Indianapolis-based company, which began with a single dump truck 71 years ago, is about to go public in a merger worth up to $345 million.
The Indianapolis-based drug company took a $1 billion charge for its sweeping early-retirement program and a $2.9 billion charge to repatriate cash in the wake of Congress' passage of tax reform.
Theratome Bio Inc. hopes to commercialize research done by Dr. Keith March of the Indiana University School of Medicine, whose previous work has produced more than 50 patents worldwide.
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
Indiana currently does not offer a license for naturopathic medicine, but 21 other states do. Several of those states, however, still prohibit naturopath practitioners from calling themselves physicians.
A slimmed-down Eli Lilly and Co., thousands of employees lighter after its biggest restructuring in nearly a decade, is now looking high and low for deals to bulk up its drug pipeline.
Methodist Sports Medicine, a private chain of orthopedic and sports clinics in central Indiana, is expanding into southern Indiana with the acquisition of Bloomington Bone & Joint Clinic.
In recent years, some Hoosiers have needed to drive nearly two hours to get treatment for addiction. The new bill would increase the number of centers by 50 percent.
An employee of Nightingale Home Health Care claimed in a lawsuit that company president Dev Brar made unwanted sexual advances. The suit was dismissed, but Brar said his insurer should have paid for his defense.
Senate Bill 28 would offer grants of $5,000 a year to eligible instructors at Indiana nursing programs, with a lifetime cap of $25,000.
A wide array of cities, towns and counties are blaming opioid makers and distributors for flooding their communities with addictive painkillers.
An alliance of doctors, hospitals, insurers and employers wants to roll back a 27-year-old Indiana law that prohibits employers from screening job candidates for tobacco use.
The medical-device industry will see a resumption of the 2.3 percent federal excise tax beginning this month, following a two-year moratorium that expired Dec. 31.